Smoking molecular damage in bronchial epithelium

Oncogene

Volumn 21, Issue 6, 2002, Pages 7298-7306

  Wistuba, Ignacio I ^a   Mao, Li ^b   Gazdar, Adi F ^c,d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Lung cancer; Preneoplasia; Smoking

Indexed keywords

ARTICLE; BRONCHUS MUCOSA; CANCER PREVENTION; CHROMOSOME ANALYSIS; EARLY DIAGNOSIS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LUNG CANCER; ONCOGENE; PATIENT MONITORING; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING;

BRONCHI; EPITHELIAL CELLS; GENETIC MARKERS; HUMANS; LUNG NEOPLASMS; SMOKING;

BRONCHUS;

EID: 0037152658     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205806     Document Type: Article

References (49)

1. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wu L, Decker PA, Jen J and Sidransky D. (1999). J. Natl. Cancer Inst., 91, 332-339.
2. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K and Herman JG. (2001). Hum. Mol. Genet., 10, 687-692.
3. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB and Herman JG. (1998). Proc. Natl. Acad. Sci. USA, 95, 11891-11896.
4. Betticher DC, Heighway J, Thatcher N and Hasleton PS. (1997). Br. J. Cancer, 75, 1761-1768.
5. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M and Minna JD. (2001). J. Natl. Cancer Inst., 93, 691-699.
6. Colby TV, Wistuba II and Gazdar A. (1998). Adv. Anat. Pathol., 5, 205-215.
7. Esteller M, Corn PG, Baylin SB and Herman JG. (2001). Cancer Res., 61, 3225-3229.
8. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, Ritchey DM and Miller YE. (1997). J. Clin. Invest., 100, 2133-2137.
9. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF and Minna JD. (2000). Cancer Res., 60, 4894-4906.
10. Greenlee RT, Hill-Harmon MB, Murray T and Thun M. (2001). CA Cancer J. Clin., 51, 15-36.
11. Hanahan D. (2000). Nature, 406, 573-574.
12. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC. (1990). Nature, 346, 866-868.
13. Hittelman WN (ed). (1999). Molecular Pathology of Early Cancer. Srivastava S, Gazdar AF and Henson DE (eds). The Netherlands: IOS Press: Van Demanstratt, pp. 385-404.
14. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW. (1995). J. Natl. Cancer Inst., 87, 895-902.
15. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD and Gazdar AF. (1995). JAMA, 273, 558-563.
16. Kersting M, Friedl C, Kraus A, Behn M, Pankow W and Schuermann M. (2000). J. Clin. Oncol., 18, 3221-3229.
17. Kishimoto Y, Sugio K, Mitsudomi T, Oyama T, Virmani A, McIntire DD and Gazdar AF. (1995). J. Natl. Cancer Inst., 87, 1224-1229.
18. Kitamura H, Kameda Y, Ito T and Hayashi H. (1999). Am. J. Clin. Pathol., 111, 610-622.
19. Knudson AG. (1989). Cancer, 63, 1888-1891.
20. Lam S, LeRiche JC, Zheng Y, Coldman A, MacAulay C, Hawk E, Kellof G and Gazdar AF. (1999). J. Natl. Cancer Inst., 91, 691-696.
21. Lang SM, Stratakis DF, Freudling A, Ebelt K, Oduncu F, Hautmann H and Huber RM. (2000). Eur. J. Med. Res., 5, 341-346.
22. Lee JJ, Liu D, Lee JS, Kurie JM, Khuri FR, Ibarguen H, Morice RC, Walsh G, Ro JY, Broxson A, Hong WK and Hittelman WN. (2001). J. Natl. Cancer Inst., 93, 1081-1088.
23. Mao L, Hruban RH, Boyle JO, Tockman M and Sidransky D. (1994). Cancer Res., 54, 1634-1637.
24. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN and Hong WK. (1997). J. Natl. Cancer Inst., 89, 857-862.
25. Mills NE, Fishman CL, Scholes J, Anderson SE, Rom WN and Jacobson DR. (1995). J. Natl. Cancer Inst., 87, 1056-1060.
26. Morin GB. (1989). Cell, 59, 521-529.
27. Nuorva K, Soini Y, Kamel D, Autio-Harmainen H, Risteli L, Risteli J, Vahakangas K and Paakko P. (1993). Am. J. Pathol., 142, 725-732.
28. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG and Belinsky SA. (2000). Cancer Res., 60, 5954-5958.
29. Park IW, Wistuba II, Maitra A, Milchgrub S, Virmani AK, Minna JD and Gazdar AF. (1999). J. Natl. Cancer Inst., 91, 1863-1868.
30. Peto R, Darby S, Deo H, Silcocks P, Whitley E and Doll R. (2000). BMJ, 321, 323-329.
31. Sekido Y, Fong KM and Minna JD. (1998). Biochim. Biophys. Acta, 1378, F21-F59.
32. Shivapurkar N, Virmani AK, Wistuba II, Milchgrub S, Mackay B, Minna JD and Gazdar AF. (1999). Clin. Cancer Res., 5, 17-23.
33. Smith AL, Hung J, Walker L, Rogers TE, Vuitch F, Lee E and Gazdar AF. (1996). Br. J. Cancer, 73, 203-209.
34. Soria JC, Moon C, Wang L, Hittelman WN, Jang SJ, Sun SY, Lee JJ, Liu D, Kurie JM, Morice RC, Lee JS, Hong WK and Mao L. (2001). J. Natl. Cancer Inst., 93, 1257-1263.
35. Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK and Mao L. (2002). Cancer Res., 62, 351-355.
36. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM and Rabbitts P. (1992). Oncogene, 7, 1989-1997.
37. Toyooka S, Toyooka KO, Maruyama R, Virmani AK, Girard L, Miyajima K, Harada K, Takahashi T, Sugio K, Brambilla E, Gilcrease M, Minna JD and Gazdar AF. (2001). Molecular Cancer Therapeutics, 1, 61-67.
38. Viallet J and Sausville EA. (1996). J. Cell Biochem. Suppl., 24, 228-236.
39. Virmani AK, Fong KM, Kodagoda D, McIntire D, Hung J, Tonk V, Minna JD and Gazdar AF. (1998). Genes Chromosomes Cancer, 21, 308-319.
40. Virmani AK, Rahti A, Zöchbauer-Müller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD and Gazdar AF. (2000). J. Natl. Cancer Inst., 92, 1303-1307.
41. Westra WH, Slebos RJ, Offerhaus GJ, Goodman SN, Evers SG, Kensler TW, Askin FB, Rodenhuis S and Hruban RH. (1993). Cancer, 72, 432-438.
42. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon 3rd JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF and Minna JD. (2000a). Cancer Res., 60, 1949-1960.
43. Wistuba II, Behrens C, Virmani AK, Milchgrub S, Syed S, Lam S, Mackay B, Minna JD and Gazdar AF. (1999a). Cancer Res., 59, 1973-1979.
44. Wistuba II, Berry J, Behrens C, Maitra A, Shivapurkar N, Milchgrub S, Mackay B, Minna JD and Gazdar AF. (2000b). Clin. Cancer Res., 6, 2604-2610.
45. Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD and Gazdar AF. (1999b). Oncogene, 18, 643-650.
46. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD and Gazdar AF. (1997). J. Natl. Cancer Inst., 89, 1366-1373.
47. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, Milchgrub S, Srivastava S, Piatyszek MA, Shay JW and Gazdar AF. (1997). Cancer Res., 57, 2373-2377.
48. Zochbauer-Muller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF and Minna JD. (2001a). Cancer Res., 61, 3581-3585.
49. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF and Minna JD. (2001b). Cancer Res., 61, 249-255.